PASG:NASDAQPassage Bio, Inc. analysis

Passage Bio, Inc. is priced at $3.58 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 23.0%. RSI sits at 37.3, which reads as approaching oversold, and MACD momentum is bearish. Watch $3.37 as support and $5.07 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 333.0% above the current price.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 100.0%, a beta of 2.69 and a maximum drawdown of 82.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 88 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 2/10 conviction on the long call.